Drugs / AGN-190168 Formulation 2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02218034 | Aug 2014 → Mar 2015 | acne | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN-190168 Formulation 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02218034 ↗ |
| Route | Topical | “applied topically to the face, neck, upper chest, upper back, and shoulders” NCT02218034 ↗ |